Brooks Laboratories Ltd
₹65.54
(6.54%)
Tue, 13 Oct 2026, 08:30 pm
Health Technology
Pharmaceuticals: Major
24.5KBrooks Laboratories Shareholding
| Shareholders | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 |
|---|---|---|---|---|---|
| Promoters | 52.62 | 52.62 | 52.62 | 52.62 | 52.62 |
| FII | 0.00 | 0.17 | 0.09 | 0.01 | 0 |
| DII | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 |
| Public | 37.00 | 36.84 | 36.91 | 37.00 | 37.00 |
| Government | 0 | 0 | 0 | 0 | 0 |
Brooks Laboratories Ltd Shareholding Pattern
The Brooks Laboratories Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Brooks Laboratories Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Brooks Laboratories Ltd (NSE: BROOKS, BSE: 533543) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Brooks Laboratories Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Brooks Laboratories Ltd Shareholding Pattern (Latest)
The latest Brooks Laboratories Ltd shareholding for Jun 2026 is:
- Promoters: 52.62%
- FII: 0.00%
- DII: 10.38%
- Public: 37.00%
- Government: 0%
Promoter holding in Brooks Laboratories Ltd remains stable, reflecting consistent long-term commitment.
Brooks Laboratories Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Brooks Laboratories Ltd.
- Jun 2026: 52.62%
- Mar 2026: 52.62%
- Dec 2025: 52.62%
- Sept 2025: 52.62%
- Jun 2025: 52.62%
Promoter stake remains largely stable, showing consistent ownership structure.
Brooks Laboratories Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Brooks Laboratories Ltd.
- Jun 2026: 0.00%
- Mar 2026: 0.17%
- Dec 2025: 0.09%
- Sept 2025: 0.01%
- Jun 2025: 0%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Brooks Laboratories Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Jun 2026: 10.38%
- Mar 2026: 10.38%
- Dec 2025: 10.38%
- Sept 2025: 10.38%
- Jun 2025: 10.38%
DII holdings remain stable, reflecting steady institutional participation.
Brooks Laboratories Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Jun 2026: 37.00%
- Mar 2026: 36.84%
- Dec 2025: 36.91%
- Sept 2025: 37.00%
- Jun 2025: 37.00%
Public participation in Brooks Laboratories Ltd has increased, indicating rising retail investor interest.
Brooks Laboratories Ltd Government Holding
Government holding in Brooks Laboratories Ltd currently stands at 0%.
Brooks Laboratories Ltd operates without significant government ownership.
Brooks Laboratories Ltd Shareholding Analysis Summary
The Brooks Laboratories Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Brooks Laboratories Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Brooks Laboratories Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
